Profile data is unavailable for this security.
About the company
Poltreg SA is a Poland-based company engaged primarily in biotechnology and medical research. The Company conducts research in the field of autoimmunological diseases. The Company works on a method of healing, that uses t-regulated cells (TREGs). The Firm possesses its own, patented technology to obtain T-regulated lymphocytes, that are used in the therapy. The Company works on therapy for diseases such as type one diabetes, type two diabetes, and multiple sclerosis. In its research, the Company cooperates with multiple specialists from various fields of science. The Company is developing its own research center, which is intended as a basic location for conducting future research activities.
- Revenue in PLN (TTM)600.00k
- Net income in PLN-17.42m
- Incorporated2016
- Employees23.00
- LocationPoltreg SABotaniczna 20GDANSK 80-298PolandPOL
- Websitehttps://poltreg.tech/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Read Gene SA | 11.63m | -1.00m | 58.36m | 11.00 | -- | 31.28 | -- | 5.02 | -0.1084 | -0.1084 | 1.16 | 0.1583 | 0.9731 | 51.32 | 18.69 | -- | -8.40 | -1.06 | -8.56 | -1.31 | 92.67 | 88.41 | -8.63 | -2.42 | 23.52 | -2.46 | 0.00 | -- | 40.14 | 16.00 | -731.53 | -- | -- | -- |
| Pure Biologics SA | 68.00k | -23.01m | 70.92m | 11.00 | -- | -- | -- | 1,042.89 | -7.09 | -8.27 | 0.0211 | -1.82 | 0.0016 | -- | 0.469 | 1,333.33 | -53.52 | -65.91 | -85.74 | -109.50 | -1,457.35 | 6.97 | -33,838.23 | -487.38 | -- | -7.36 | -- | -- | -85.65 | -60.22 | -39.41 | -- | 1.65 | -- |
| Sds Optic SA | 370.00 | -8.98m | 78.76m | -- | -- | -- | -- | 212,862.60 | -1.52 | -1.52 | 0.00006 | -0.0545 | 0.00003 | 65.75 | 0.0006 | -- | -74.69 | -- | -86.32 | -- | -371,002.80 | -- | -2,452,795.00 | -- | 9.61 | -47.49 | -- | -- | -99.61 | -- | -85.09 | -- | -- | -- |
| Nanogroup SA | 1.02k | -7.12m | 84.24m | -- | -- | 9.04 | -- | 82,591.21 | -0.3541 | -0.3541 | 0.00005 | 0.3253 | 0.00007 | 7.84 | 0.0141 | -- | -45.22 | -23.18 | -51.42 | -26.06 | -99,397.06 | -278.03 | -692,468.60 | -1,567.57 | 2.75 | -858.81 | 0.00 | -- | -98.55 | -55.07 | -840.84 | -- | -8.99 | -- |
| Genomtec SA | 2.00k | -11.00m | 94.26m | -- | -- | 8.03 | -- | 47,131.57 | -0.8971 | -0.8971 | 0.0002 | 0.9582 | 0.00009 | 62.24 | 0.0011 | -- | -47.25 | -- | -60.10 | -- | -115,050.00 | -- | -549,850.00 | -- | 2.06 | -88.39 | 0.1442 | -- | -97.50 | -- | 24.44 | -- | -- | -- |
| Urteste SA | 0.00 | -4.28m | 125.46m | -- | -- | 4.85 | -- | -- | -3.15 | -3.15 | 0.00 | 18.34 | 0.00 | 11.94 | -- | -- | -14.28 | -- | -14.78 | -- | -- | -- | -- | -- | 17.80 | -- | 0.026 | -- | -100.00 | -- | -37.59 | -- | -- | -- |
| Molecure SA | 712.18k | -27.63m | 168.70m | 105.00 | -- | 2.11 | -- | 236.87 | -1.64 | -1.64 | 0.0423 | 4.76 | 0.0054 | -- | 1.06 | 6,416.04 | -21.00 | 2.64 | -21.93 | 2.76 | -272.51 | 97.54 | -3,879.55 | 12.84 | -- | -- | 0.0649 | -- | -18.85 | 237.24 | -19.67 | -- | -24.82 | -- |
| Mabion SA | 110.79m | 10.24m | 198.47m | 226.00 | 19.38 | 1.53 | 10.35 | 1.79 | 0.6336 | 0.6336 | 6.86 | 8.00 | 0.5407 | 3.12 | 19.98 | 490,238.90 | 5.00 | -7.19 | 7.00 | -16.79 | 78.29 | 58.10 | 9.24 | -14.27 | 1.26 | 18.35 | 0.0281 | -- | -7.50 | -- | 77.94 | -- | 40.86 | -- |
| Poltreg SA | 600.00k | -17.42m | 235.97m | 23.00 | -- | 2.97 | -- | 393.28 | -3.74 | -3.74 | 0.1287 | 17.04 | 0.0051 | 27.12 | 3.22 | 26,373.63 | -14.82 | -6.51 | -16.41 | -7.35 | -1,804.83 | -391.38 | -2,903.50 | -449.24 | 4.21 | -- | 0.0913 | -- | 40.04 | -- | -588.92 | -- | 214.26 | -- |
| BIOTON SA | 186.32m | -6.85m | 270.47m | 358.00 | -- | 0.4519 | 10.49 | 1.45 | -0.0797 | -0.0797 | 2.17 | 6.97 | 0.2303 | 1.02 | 21.19 | 520,435.80 | -0.8464 | -1.99 | -1.04 | -2.47 | 33.80 | 45.33 | -3.67 | -8.61 | 0.2085 | 0.3295 | 0.0864 | -- | -22.10 | -5.51 | 60.10 | -38.69 | 0.3284 | -- |
| Captor Therapeutics SA | 18.64m | -46.69m | 291.89m | 104.00 | -- | 5.76 | -- | 15.66 | -10.29 | -10.29 | 4.08 | 10.87 | 0.2391 | -- | 5.26 | 179,230.80 | -59.88 | -- | -83.65 | -- | 51.97 | -- | -250.46 | -- | -- | -- | 0.1114 | -- | 44.15 | -- | -96.65 | -- | -- | -- |
| Scope Fluidics SA | 98.00k | -26.68m | 454.69m | 40.00 | -- | 6.74 | -- | 4,639.64 | -9.79 | -9.79 | 0.036 | 24.76 | 0.001 | 2.53 | 0.0716 | 2,450.00 | -27.04 | 52.74 | -28.55 | 57.32 | -2,013.27 | -420.87 | -27,227.55 | 30,134.78 | 11.32 | -- | 0.0301 | -- | 27.72 | -- | -105.76 | -- | 89.99 | -- |
Data as of Nov 08 2024. Currency figures normalised to Poltreg SA's reporting currency: Polish New Zloty PLN
13.03%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Allianz Polska PTE SAas of 12 May 2023 | 356.00k | 7.63% |
| Allianz Polska TFI SAas of 31 Dec 2023 | 140.43k | 3.01% |
| Norges Bank Investment Managementas of 30 Jun 2024 | 65.00k | 1.39% |
| Aviva Investors Poland Towarzystwo Funduszy Inwestycyjnych SAas of 30 Jun 2023 | 46.37k | 0.99% |
| PTE PZU SAas of 30 Jun 2023 | 0.00 | 0.00% |
More ▼
Data from 30 Jun 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
